
Xultophy Coupons & Discount Card – Guaranteed Prices from $258.15
My prescription
Edit
5 solution pen-injectors 3ML of 100-3.6UNIT-MG/ML, Xultophy (1 Pen)
Select pharmacy

CVS
$259.76
COUPON PRICE
Rite Aid
$258.15
COUPON PRICE
Walmart
$259.41
COUPON PRICE
Walgreens
$270.40
COUPON PRICEXultophy savings card
Show this card to your pharmacist
Rite Aid
$258.15
BIN
ID
PCN
GRP
019876
LH5E55AA93
CHIPPO
LHX
Powered by
More prescriptions for diabetes type 2
More prescriptions for diabetes type 2
Xultophy dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
5 solution pen-injectors 3ML of 100-3.6UNIT-MG/ML | 1 Pen | $255.69 | $255.69 |
Xultophy Warnings
This medication has been associated with the development of specific thyroid tumors, known as thyroid C-cell tumors, in animal studies involving rats and mice. However, it is not yet confirmed if it poses the same risk to humans. It is crucial to discuss the potential benefits and risks of this treatment with your healthcare provider.
Please avoid using this medication if you have a specific genetic condition called multiple endocrine neoplasia syndrome type 2 (MEN 2) or if there is a personal or family history of medullary thyroid carcinoma.
While undergoing treatment, promptly inform your doctor if you experience any indications of thyroid tumors. These signs include an unusual growth or lump in the neck, difficulty swallowing, shortness of breath, or persistent hoarseness.
By adhering to these guidelines, you can ensure the safe and effective use of this medication.
Xultophy Side Effects
When taking this medication, you may experience some common side effects such as nausea, headache, diarrhea, constipation, stomach upset, decreased appetite, weight gain, stuffy or runny nose, and reactions at the injection site like pain or redness. These effects are usually mild and often resolve as your body adjusts to the medication. If they persist or worsen, consult your healthcare provider for advice.
Low blood sugar is a relatively common side effect, occurring in up to 37% of users. Symptoms include sweating, shaking, hunger, dizziness, and tingling in the hands or feet. To manage this, keep glucose tablets or sugary foods on hand. Other side effects, like vomiting, heartburn, and swelling, are less common but still noteworthy.
Serious side effects are rare but require immediate medical attention. These include symptoms of thyroid cancer such as a neck mass or hoarseness, pancreatitis marked by severe stomach pain radiating to the back, and symptoms of gallbladder issues like jaundice and fever. Kidney damage, indicated by tiredness and changes in urination, and dangerously low potassium levels, signaled by muscle cramps and abnormal heartbeat, also necessitate urgent care. Allergic reactions, although very rare, can be severe, with symptoms such as rash, swelling, and difficulty breathing.
It's important to be aware of these potential side effects and to seek medical attention if you experience any severe or concerning symptoms. Always communicate with your healthcare provider to ensure the best management of your treatment.
Xultophy Interactions
What type of insulin is in Xultophy?
Xultophy contains insulin degludec, which is a long-acting insulin.
Does Xultophy cause weight loss?
Xultophy is not primarily associated with weight loss. It is a combination medication used to improve blood sugar control in adults with type 2 diabetes. While some patients may experience weight changes, weight loss is not a common effect of Xultophy. Patients should discuss any concerns about weight changes with their healthcare provider.
Is Xultophy the same as Tresiba?
Xultophy and Tresiba are not the same. Xultophy is a combination medication that contains insulin degludec (Tresiba) and liraglutide, a GLP-1 receptor agonist. Tresiba, on the other hand, contains only insulin degludec. They are used for managing diabetes but have different compositions and mechanisms of action.
What insulin is comparable to Xultophy?
Xultophy is a combination of insulin degludec and liraglutide. Insulin degludec, a long-acting insulin, is comparable to other long-acting insulins such as insulin glargine (found in Lantus or Toujeo) and insulin detemir (found in Levemir). However, Xultophy also contains liraglutide, a GLP-1 receptor agonist, which makes it unique. There is no direct single insulin product that is entirely comparable to Xultophy due to this combination.
Can you lose weight on Xultophy?
Xultophy is a medication that combines insulin degludec and liraglutide. While its primary use is to improve blood sugar control in adults with type 2 diabetes, some patients may experience weight loss as a side effect due to the liraglutide component, which can reduce appetite. However, weight changes can vary among individuals, and it is important to follow a healthcare provider's guidance for managing weight and diabetes.